{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:51:59Z","timestamp":1777679519555,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"DOI":"10.7759\/cureus.105494","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:07:36Z","timestamp":1773925656000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Palbociclib-Induced Pancolitis: Clinical Insights and Literature Review"],"prefix":"10.7759","author":[{"given":"Khyati","family":"Bidani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek A","family":"Chouthai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkady","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sugirdhana","family":"Velpari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2021.1852934","article-title":"CDK4\/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis","volume":"21","author":"Onesti CE","year":"2021","unstructured":"Onesti CE, Jerusalem G. CDK4\/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis. Expert Rev Anticancer Ther. 2021, 21:283-298. 10.1080\/14737140.2021.1852934","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102086","article-title":"Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4\/6 inhibitors in metastatic breast cancer: a network meta-analysis","volume":"90","author":"Desnoyers A","year":"2020","unstructured":"Desnoyers A, Nadler MB, Kumar V, Saleh R, Amir E. Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4\/6 inhibitors in metastatic breast cancer: a network meta-analysis. Cancer Treat Rev. 2020, 90:102086. 10.1016\/j.ctrv.2020.102086","journal-title":"Cancer Treat Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-024-00770-6","article-title":"Comparative analysis of adverse events associated with CDK4\/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study","volume":"25","author":"Lin W","year":"2024","unstructured":"Lin W, Zeng Y, Weng L, Yang J, Zhuang W. Comparative analysis of adverse events associated with CDK4\/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study. BMC Pharmacol Toxicol. 2024, 25:47. 10.1186\/s40360-024-00770-6","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051775","article-title":"Sticking to the rules: outcome and success rate of guideline-based diarrhea management in metastatic breast cancer patients treated with abemaciclib","volume":"12","author":"Jacobs F","year":"2023","unstructured":"Jacobs F, Agostinetto E, Solferino A, Torrisi R, Masci G, Santoro A, De Sanctis R. Sticking to the rules: outcome and success rate of guideline-based diarrhea management in metastatic breast cancer patients treated with abemaciclib. J Clin Med. 2023, 12:1775. 10.3390\/jcm12051775","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242766","article-title":"CDK4\/6 inhibitor-induced colitis: a case report and review of the literature","volume":"14","author":"Malik AA","year":"2021","unstructured":"Malik AA, Abbas H, Oo ZM, Lim Z. CDK4\/6 inhibitor-induced colitis: a case report and review of the literature. BMJ Case Rep. 2021, 14:e242766. 10.1136\/bcr-2021-242766","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000870316.80825.04","article-title":"Ileocolitis associated with the checkpoint inhibitor palbociclib (PAL)","volume":"117","author":"Gomez C","year":"2022","unstructured":"Gomez C, Bierman T, Clarkston W. Ileocolitis associated with the checkpoint inhibitor palbociclib (PAL). Am J Gastroenterol. 2022, 117:e2158. 10.14309\/01.ajg.0000870316.80825.04","journal-title":"Am J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13691","article-title":"Management of abemaciclib-associated adverse events in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: safety analysis of MONARCH 2 and MONARCH 3","volume":"26","author":"Rugo HS","year":"2021","unstructured":"Rugo HS, Huober J, Garc\u00eda-S\u00e1enz JA, et al.. Management of abemaciclib-associated adverse events in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: safety analysis of MONARCH 2 and MONARCH 3. Oncologist. 2021, 26:e522. 10.1002\/onco.13691","journal-title":"Oncologist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467563-a-rare-case-of-palbociclib-induced-pancolitis-clinical-insights-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:07:37Z","timestamp":1773925657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467563-a-rare-case-of-palbociclib-induced-pancolitis-clinical-insights-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.105494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}